Peter Bains resigns as MD and CEO of Syngene International

Ceo ResignedManagement Changes View source PDF Explain this filing

SYNGENE · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-2.3%Reaction day

₹441.05

prior close

₹444.00

announcement price

After-mkt

timing

Nifty Smallcap 250market+0.5%-2.8% vs market

Healthcare Research Analytics & Technology peers, median of 5sector-2.7%+0.4% vs sector

On the reaction day the stock moved 2.8 pts less than Nifty Smallcap 250 and 0.4 pts more than its Healthcare Research Analytics & Technology peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-2.1

10m

-2.5

15m

-2.0

30m

-3.1

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-2.3+0.5-2.8-2.7+0.4

Next day

-4.2-0.2-3.9-2.8-1.4

-6.2-2.2-4.0-2.6-3.6

-5.7-0.7-5.0-1.5-4.2

-4.8+0.7-5.5-0.1-4.7

-4.5+1.0-5.5+1.0-5.5

-4.8+0.6-5.3+0.4-5.2

15d

-6.4-1.0-5.4-4.4-1.9

-9.3+2.0-11.3+0.6-9.9

-11.7+2.7-14.4+15.4-27.1

-17.9-0.5-17.4-1.4-16.5

UpDownMarket · Nifty Smallcap 250Sector · Healthcare Research Analytics & Technology peers, median of 5Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Syngene International has submitted the formal resignation letter of Mr Peter Bains, who is stepping down as Managing Director and CEO effective close of business on June 30, 2026. His departure was first disclosed on March 27, 2026 as part of a planned leadership succession process. He has committed to a smooth handover during the remaining tenure.

Likely market impact

Planned CEO exit already known; formal letter removes uncertainty around transition. Watch for successor announcement.